Perrigo Enhances Consumer Health Market Strategy Ahead of UBS Global Conference

Perrigo Strengthens Market Position in Consumer Health Sector

Perrigo Company plc continues to reinforce its commitment to consumer health with the announcement of President and CEO Patrick Lockwood-Taylor's presentation at the upcoming UBS Global Consumer and Retail Conference on March 11, 2026. The event, facilitated as a webcast, underscores Perrigo's ongoing engagement with stakeholders and its strategic approach to the consumer health market. Established over a century ago, Perrigo specializes in providing accessible over-the-counter (OTC) self-care products, which is vital in responding to the evolving needs of consumers across North America and Europe.

The company’s business model is built on a dual approach of offering cash-generative store brand private-label products alongside well-established brands such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. This model allows Perrigo to maintain a competitive edge in an increasingly crowded market. By diversifying its offerings, Perrygo not only expands its portfolio but also enhances consumer choice, emphasizing quality health solutions that cater to a wide spectrum of needs. Such strategic positioning enables Perrigo to adapt to consumer trends and provide effective health solutions that consumers trust.

Furthermore, the press release from Perrigo acknowledges the inherent risks associated with forward-looking statements. As the company navigates an ever-changing market landscape, stakeholders are reminded to consider the potential uncertainties that could impact future financial outcomes. Perrigo stresses the importance of understanding its "Risk Factors," as detailed in its Form 10-K for the year ended December 31, 2025. This transparency is critical for investors and consumers alike, reinforcing Perrigo’s dedication to clear communication about its operational environment.

In addition to its proactive engagement with investors, Perrigo encourages interested parties to explore its financial filings available through the United States Securities and Exchange Commission. The company's Global Investor Relations team remains accessible for any inquiries, further enhancing its commitment to stakeholder engagement. For more comprehensive insights into Perrigo's initiatives and offerings, the company directs stakeholders to its official website.

As Perrigo prepares for its presentation at the UBS Conference, it remains focused on innovation and the delivery of high-quality health and wellness solutions, solidifying its role as a leading provider in the consumer health sector.